Hanyuda et al. indeed investigated the relationship between BMI and risk of CRC, defined by the levels of CD3+, CD8+, FoxP3+, and CD45RO+ T cells, but found no heterogeneous associations.14 Potential sex differences were, however, not considered. The gene discussed is FOXP3; the disease is colorectal carcinoma.